BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 71 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $87,000 | +13.0% | 25,683 | -3.1% | 0.00% | – |
| Q4 2018 | $77,000 | -53.3% | 26,515 | -0.8% | 0.00% | -100.0% |
| Q3 2018 | $165,000 | -14.1% | 26,720 | +3.0% | 0.00% | 0.0% |
| Q2 2018 | $192,000 | +68.4% | 25,949 | +49.4% | 0.00% | – |
| Q1 2018 | $114,000 | -26.0% | 17,369 | -5.1% | 0.00% | -100.0% |
| Q4 2017 | $154,000 | -26.7% | 18,303 | +0.5% | 0.00% | 0.0% |
| Q3 2017 | $210,000 | +6.6% | 18,216 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $197,000 | +23.9% | 16,854 | +30.6% | 0.00% | 0.0% |
| Q1 2017 | $159,000 | -3.0% | 12,902 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $164,000 | -99.9% | 12,050 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $240,432,000 | +53.8% | 12,082 | +0.1% | 0.00% | 0.0% |
| Q2 2016 | $156,349,000 | +189.5% | 12,064 | +106.5% | 0.00% | – |
| Q1 2016 | $54,000,000 | -54.2% | 5,843 | 0.0% | 0.00% | – |
| Q4 2015 | $118,000,000 | +138723.5% | 5,843 | -0.2% | 0.00% | – |
| Q3 2015 | $85,000 | -99.9% | 5,852 | +0.1% | 0.00% | – |
| Q2 2015 | $124,366,000 | +436.8% | 5,847 | +484.7% | 0.00% | – |
| Q1 2015 | $23,170,000 | +0.6% | 1,000 | 0.0% | 0.00% | – |
| Q4 2014 | $23,040,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|